{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T18:05:45Z","timestamp":1791050745646,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1994,1,1]],"date-time":"1994-01-01T00:00:00Z","timestamp":757382400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[1994,1]]},"DOI":"10.1007\/bf03344959","type":"journal-article","created":{"date-parts":[[2014,3,29]],"date-time":"2014-03-29T06:20:48Z","timestamp":1396074048000},"page":"29-36","source":"Crossref","is-referenced-by-count":72,"title":["Antithyroid drug \u2014 induced agranulocytosis: Clinical experience with ten patients treated at one institution and review of the literature"],"prefix":"10.1007","volume":"17","author":[{"given":"M.","family":"Meyer-Ge\u00dfner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Benker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Lederbogen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Olbricht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Reinwein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,3,18]]},"reference":[{"key":"BF03344959_CR1","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0889-8529(18)30484-5","volume":"76","author":"J Orgiazzi","year":"1987","unstructured":"Orgiazzi J. Management of Graves\u2019 hyperthyroidism. Endocr. Metab. Clin. North Am. 76: 365, 1987.","journal-title":"Endocr. Metab. Clin. North Am."},{"key":"BF03344959_CR2","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1001\/jama.1943.02840190008003","volume":"122","author":"EB Astwood","year":"1943","unstructured":"Astwood E.B. Treatment of hyperthyroidism with thiourea and thiouracil. JAMA 122: 78, 1943.","journal-title":"JAMA"},{"key":"BF03344959_CR3","first-page":"319","volume":"735","author":"MS Fedotin","year":"1975","unstructured":"Fedotin M.S., Lefer L.G. Liver disease caused by propylthiouracil. Intern. Med. 735: 319, 1975.","journal-title":"Intern. Med."},{"key":"BF03344959_CR4","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/S0016-5085(76)80273-9","volume":"70","author":"AA Mihas","year":"1976","unstructured":"Mihas A.A., Holley P., Koff K.S, Hirschowitz B.J. Fulminant hepatitis and lymphocyte sensitisation due to propylthioracil. Gastroenterology 70: 770, 1976.","journal-title":"Gastroenterology"},{"key":"BF03344959_CR5","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1001\/archinte.1982.00340170198033","volume":"142","author":"MM Safan","year":"1982","unstructured":"Safan M.M., Tatro D.S., Rudd P. Fatal propylthiouracil-induced hepatitis. Arch. Int. Med. 142: 838, 1982.","journal-title":"Arch. Int. Med."},{"key":"BF03344959_CR6","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000180054","volume":"24","author":"AC Vitug","year":"1985","unstructured":"Vitug A.C., Goldman J.M. Hepatotoxicity from antithyroid drugs. Horm. Res. 24: 229, 1985.","journal-title":"Horm. Res."},{"key":"BF03344959_CR7","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1001\/archinte.1985.00360080195029","volume":"745","author":"H Blom","year":"1985","unstructured":"Blom. H., Stalk J., Schreuder M.B., von Blomberg-van der Flier M. A case of carbimazole-induced intrahepatic cholestasis. An immune-mediated reaction? Arch. Int. Med. 745: 1513, 1985.","journal-title":"Arch. Int. Med."},{"key":"BF03344959_CR8","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/0002-9343(54)90141-2","volume":"77","author":"TH McGravack","year":"1954","unstructured":"McGravack T.H., Chevalley J. Untoward hemathologic responses to the antithyroid compounds. Am. J. Med. 77: 36, 1954.","journal-title":"Am. J. Med."},{"key":"BF03344959_CR9","first-page":"124","volume":"138","author":"SB Bilezekian","year":"1976","unstructured":"Bilezekian S.B., Laleli Y., Tsan M.F., Hodgkinson B.A., Lee S., McIntyre P.A. Immunological reactions involving leukocytes: III agranulocytosis induced by antithyroid drugs. John Hopkins Med. J. 138: 124, 1976.","journal-title":"John Hopkins Med. J."},{"key":"BF03344959_CR10","first-page":"339","volume":"726","author":"MH Resove","year":"1977","unstructured":"Resove M.H. Agranulocytosis and antithyroid drugs. West Med. J. 726: 339, 1977.","journal-title":"West Med. J."},{"key":"BF03344959_CR11","first-page":"26","volume":"98","author":"DS Cooper","year":"1983","unstructured":"Cooper D.S., Goldminz D., Levin A.A., Ladenson P.W., Daniels G.H., Molich M.E., Ridgeway E.C. Agranulocytosis associated with antithyroid drugs. Effects of patient age and drug dose. Ann. Int. Med. 98: 26, 1983.","journal-title":"Effects of patient age and drug dose. Ann. Int. Med."},{"key":"BF03344959_CR12","first-page":"621","volume":"750","author":"J Tajiri","year":"1990","unstructured":"Tajiri J., Noguchi S., Murakami T., Murakami N. Antithyroid drug-induced agranulocytosis. The usefullness of routine white blood cell count monitoring. Arch. Int. Med. 750: 621, 1990.","journal-title":"The usefullness of routine white blood cell count monitoring. Arch. Int. Med."},{"key":"BF03344959_CR13","first-page":"166","volume":"114","author":"M Meyer-Ge\u00dfner","year":"1989","unstructured":"Meyer-Ge\u00dfner M., Benker G., Olbricht T., Windeck R., Reiners C., Reinwein D. Nebenwirkungen der antithyreoidalen Therapie der Hyperthyreose. Eine Untersuchung an 1256 fortlaufend betreuten Patients. Dtsch. Med. Wschr. 114: 166, 1989.","journal-title":"Eine Untersuchung an 1256 fortlaufend betreuten Patients. Dtsch. Med. Wschr."},{"key":"BF03344959_CR14","first-page":"1861","volume":"114","author":"U Rosien","year":"1989","unstructured":"Rosien U., Benker G., Brittinger G., Reinwein D. Agranulozytose-Behandlung mit rhGH-CSF. Dtsch. Med. Wschr. 114: 1861, 1989.","journal-title":"Dtsch. Med. Wschr."},{"key":"BF03344959_CR15","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1365-2125.1992.tb04031.x","volume":"33","author":"PC Waller","year":"1992","unstructured":"Waller P.C. Measuring the frequency of adverse drug reactions. Br. J. Clin. Pharmac. 33: 249, 1992.","journal-title":"Br. J. Clin. Pharmac."},{"key":"BF03344959_CR16","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1136\/bmj.1.4981.1453","volume":"1","author":"CD Burrell","year":"1956","unstructured":"Burrell C.D., Fraser R., Doniach D. The low toxicity of Carbimazole \u2014 a survey of 1046 patients. Brt. Med. J. 1: 1453, 1956.","journal-title":"Brt. Med. J."},{"key":"BF03344959_CR17","first-page":"436","volume":"9","author":"HL Kr\u00fcskemper","year":"1960","unstructured":"Kr\u00fcskemper H.L. Nebenwirkungen thyreostatischer Arzneimmittel. Der. Internist. 9: 436, 1960.","journal-title":"Der. Internist."},{"key":"BF03344959_CR18","doi-asserted-by":"crossref","unstructured":"Trotter W.R. The relative toxicity of antithyroid drugs. The Journal of New Drugs 333, 1962.","DOI":"10.1177\/009127006200200603"},{"key":"BF03344959_CR19","doi-asserted-by":"crossref","first-page":"414","DOI":"10.7326\/0003-4819-77-3-414","volume":"77","author":"JJ Wiberg","year":"1972","unstructured":"Wiberg J.J., Natall F.Q. Methimazole toxicity from high doses. Ann. Int. Med. 77: 414, 1972.","journal-title":"Ann. Int. Med."},{"key":"BF03344959_CR20","first-page":"381","volume":"45","author":"AM Guerrier Le","year":"1984","unstructured":"Le Guerrier A.M., Lorcy Y., Allanic H. Les accidents imputables au Carbimazole dans le traitment de la maladie de Basedow. Ann. Endocrinol. (Paris) 45: 381, 1984.","journal-title":"Ann. Endocrinol. (Paris)"},{"key":"BF03344959_CR21","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/bmj.297.6643.262","volume":"297","author":"J Retsagi","year":"1988","unstructured":"Retsagi J., Kelly J.P., Kaufman D.W. Risk of agranulocytosis and asplastic anemia in relation to use of antithyroid drugs. Brit. Med. J. 297: 262, 1988.","journal-title":"Brit. Med. J."},{"key":"BF03344959_CR22","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/00000441-198904000-00003","volume":"297","author":"MC Werner","year":"1989","unstructured":"Werner M.C., Romaldini J.H., Bromberg N., Werner R.S., Farah C.S. Adverse effects related to thionamide drugs and their dose regimen. Am. J. Med. Sc. 297: 216, 1989.","journal-title":"Am. J. Med. Sc."},{"key":"BF03344959_CR23","first-page":"412","volume":"30","author":"SL Edell","year":"1975","unstructured":"Edell S.L, Bartuska D.G. Aplastic anemia secondary to methimazole-a case report and review of the hematologic side effects. J. Am. Med. Wom. Assoc. 30: 412, 1975.","journal-title":"J. Am. Med. Wom. Assoc."},{"key":"BF03344959_CR24","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1365-2265.1989.tb01424.x","volume":"30","author":"H Tamai","year":"1989","unstructured":"Tamai H. Takaichi Y., Morita T., Komaki G., Mutsubayashi S., Kuma K., Walter jr. R.M., Kumagai L.F., Nataki S. Methimazole-induced agranulocytosis in Japanese patients with Graves\u2019 disease. Clin. Endocrinol. (Oxf.) 30: 525, 1989.","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BF03344959_CR25","first-page":"401","volume":"26","author":"Y Hirata","year":"1977","unstructured":"Hirata Y., Tasaka Y., Ogadiri R., Takei M., Kenbo T., Horino M. A new type of hypoglycemia with spontaneous insulin autoantibodies. Diabetes 26: 401, 1977.","journal-title":"Diabetes"},{"issue":"150A","key":"BF03344959_CR26","volume":"32","year":"1983","unstructured":"Tahayama S., Hirata Y. Incidence of insulin autoimmune hypoglycemia in Japan during the three-year period from 1971\u20131981. Diabetes 32: Suppl. 150A, 1983.","journal-title":"Diabetes"},{"key":"BF03344959_CR27","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1210\/jcem-57-6-1140","volume":"57","author":"T Sanke","year":"1983","unstructured":"Sanke T., Kondo M., Moriyama Y., Nanjo K., Iwo K., Miyamura K. Glucagon binding autoantibodies in a patient with hyperthyroidism treated with methimazole. J. Clin. Endocrinol. Metab. 57: 1140, 1983.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03344959_CR28","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/BF00625803","volume":"77","author":"A Melander","year":"1980","unstructured":"Melander A., Hallergren B., Rosendal-Helgesen S., Sj\u00f6berg A-K., Wahlin-Boll E. Comparative in-vitro effects and in vivo kinetics of antithyroid drugs. Eur. J. Clin. Pharmacol. 77: 295, 1980.","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"BF03344959_CR29","unstructured":"Wing S.S., Fantus G. Adverse immunologic effects of antithyroid drugs. Can. Med. Assoc. J. 121, 1987."},{"key":"BF03344959_CR30","doi-asserted-by":"crossref","first-page":"283","DOI":"10.7326\/0003-4819-101-2-283_2","volume":"101","author":"DS Cooper","year":"1984","unstructured":"Cooper D.S., Daniels G.H., Ridgewayn E.C. Agranulocytosis and dose of methimazole. Ann. Int. Med. 101: 283, 1984.","journal-title":"Ann. Int. Med."},{"key":"BF03344959_CR31","first-page":"1361","volume-title":"The Pharmacologicical Basis of Therapeutics","author":"RC Haynes","year":"1990","unstructured":"Haynes R.C. Thyroid and antithyroid drugs. In: Goodman Gilman A., Rall T.W., Nies A.S., Taylor P. (Eds.) The Pharmacologicical Basis of Therapeutics. 8 ed. Pergamon press, New York 1990, p. 1361.","edition":"8"},{"key":"BF03344959_CR32","doi-asserted-by":"crossref","first-page":"621","DOI":"10.7326\/0003-4819-111-7-621_2","volume":"111","author":"B Heinrich","year":"1989","unstructured":"Heinrich B., Gross M., Goebel F.D. Methimazole-induced agranulocytosis and Granulocyte-colony stimulating factor. Ann. Int. Med. 111: 621, 1989.","journal-title":"Ann. Int. Med."}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03344959.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03344959\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03344959","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T21:58:34Z","timestamp":1565301514000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03344959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1994,1]]}},"alternative-id":["BF03344959"],"URL":"https:\/\/doi.org\/10.1007\/bf03344959","relation":{},"ISSN":["0391-4097","1720-8386"],"issn-type":[{"value":"0391-4097","type":"print"},{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994,1]]}}}